Listed

Medifast Inc

MEDNYSECIK 910329Consumer staplesFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$76.4mRevenue, Q2 FY2026, three months to 2026-06-30$76.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 3, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$76.4mRevenue, Q2 FY2026, three months to 2026-06-30$76.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure−27.6% on a year earlier
  • Gross margin69.9%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $53.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Revenue: $76.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure−2.7 pts on a year earlier
  • Operating margin−5.7%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$4.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Revenue: $76.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure−4.7 pts on a year earlier
  • Net margin−4.1%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Revenue: $76.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure−6.4 pts on a year earlier
  • Diluted EPS−$0.28Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figureSign changed from a year earlier
  • Free cash flow$728.0kFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001628280-26-051928. Derived: 6-month figure less the 3-month figure.Capital expenditure: $969.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001628280-26-051928. Derived: 6-month figure less the 3-month figure.Report this figureSign changed from a year earlier

Last eight quarters

Full statements
Revenue$76.4mGross margin 69.9%
Diluted EPS−$0.28, Q2 FY2026
Free cash flow$728.0k, Q2 FY2026
Medifast Inc, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m140Revenue, Q3 FY2024, three months to 2024-09-30$140.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure119Revenue, Q4 FY2024, three months to 2024-12-31$119.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure116Revenue, Q1 FY2025, three months to 2025-03-31$115.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure106Revenue, Q2 FY2025, three months to 2025-06-30$105.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure89.4Revenue, Q3 FY2025, three months to 2025-09-30$89.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure75.1Revenue, Q4 FY2025, three months to 2025-12-31$75.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure76.0Revenue, Q1 FY2026, three months to 2026-03-31$76.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure76.4Revenue, Q2 FY2026, three months to 2026-06-30$76.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Gross margin%75.4%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $105.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Revenue: $140.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure74.1%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $88.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Revenue: $119.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure72.8%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $84.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Revenue: $115.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure72.6%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $76.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Revenue: $105.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure69.5%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $62.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Revenue: $89.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure69.4%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $52.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Revenue: $75.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure68.1%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $51.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Revenue: $76.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure69.9%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $53.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Revenue: $76.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Operating margin%1.5%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $2.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Revenue: $140.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure0.6%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $709.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Revenue: $119.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure(1.1%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Revenue: $115.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure(1.0%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Revenue: $105.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure(4.6%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Revenue: $89.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure(10.4%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$7.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Revenue: $75.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure(4.3%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Revenue: $76.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure(5.7%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$4.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Revenue: $76.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Net margin%0.8%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Revenue: $140.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure0.7%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $801.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Revenue: $119.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure(0.7%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$772.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Revenue: $115.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure2.3%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Revenue: $105.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure(2.5%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Revenue: $89.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figure(24.1%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$18.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Revenue: $75.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure(2.8%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$2.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Revenue: $76.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure(4.1%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Revenue: $76.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Diluted EPS$ per share0.10Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figurenot reported (Diluted EPS not reported)(0.07)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure0.22Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure(0.21)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001628280-25-048332.Report this figurenot reported (Diluted EPS not reported)(0.19)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure(0.28)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001628280-26-051928.Report this figure
Free cash flow$m7.7Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $9.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001628280-25-048332. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001628280-25-048332. Derived: 9-month figure less the 6-month figure.Report this figure(7.2)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Capital expenditure: $2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure1.9Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Capital expenditure: $1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure(4.8)Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001628280-26-051928. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001628280-26-051928. Derived: 6-month figure less the 3-month figure.Report this figure10.8Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $12.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001628280-25-048332. Derived: 9-month figure less the 6-month figure.Capital expenditure: $1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0001628280-25-048332. Derived: 9-month figure less the 6-month figure.Report this figure(6.6)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Capital expenditure: $1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001628280-26-008656. Derived: 12-month figure less the 9-month figure.Report this figure(0.8)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $260.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Capital expenditure: $1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-04, accession 0001628280-26-029898.Report this figure0.7Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001628280-26-051928. Derived: 6-month figure less the 3-month figure.Capital expenditure: $969.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0001628280-26-051928. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$385.8mGross margin 71.3%
Diluted EPS−$1.70, FY2025
Free cash flow$1.2m, FY2025
Medifast Inc, key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m1,526Revenue, FY2021, twelve months to 2021-12-31$1.53bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-20, accession 0001628280-24-005620.Report this figure1,599Revenue, FY2022, twelve months to 2022-12-31$1.60bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-18, accession 0001628280-25-006094.Report this figure1,072Revenue, FY2023, twelve months to 2023-12-31$1.07bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure602Revenue, FY2024, twelve months to 2024-12-31$602.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure386Revenue, FY2025, twelve months to 2025-12-31$385.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure
Gross margin%73.9%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $1.13bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-20, accession 0001628280-24-005620.Revenue: $1.53bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-20, accession 0001628280-24-005620.Report this figure71.3%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $1.14bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-18, accession 0001628280-25-006094.Revenue: $1.60bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-18, accession 0001628280-25-006094.Report this figure72.4%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $775.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0001628280-26-008656.Revenue: $1.07bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure73.8%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $444.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0001628280-26-008656.Revenue: $602.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure71.3%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $275.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0001628280-26-008656.Revenue: $385.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure
Operating margin%14.2%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $216.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-20, accession 0001628280-24-005620.Revenue: $1.53bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-20, accession 0001628280-24-005620.Report this figure11.6%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $184.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-18, accession 0001628280-25-006094.Revenue: $1.60bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-18, accession 0001628280-25-006094.Report this figure11.8%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $126.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656.Revenue: $1.07bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure0.5%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656.Revenue: $602.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure(3.7%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$14.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656.Revenue: $385.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure
Net margin%10.7%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $164.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-20, accession 0001628280-24-005620.Revenue: $1.53bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-20, accession 0001628280-24-005620.Report this figure9.0%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $143.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-18, accession 0001628280-25-006094.Revenue: $1.60bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-18, accession 0001628280-25-006094.Report this figure9.3%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $99.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656.Revenue: $1.07bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure0.3%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $2.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656.Revenue: $602.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure(4.8%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$18.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001628280-26-008656.Revenue: $385.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure
Diluted EPS$ per share13.89Diluted EPS, FY2021, twelve months to 2021-12-31$13.89 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-20, accession 0001628280-24-005620.Report this figure12.73Diluted EPS, FY2022, twelve months to 2022-12-31$12.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-18, accession 0001628280-25-006094.Report this figure9.10Diluted EPS, FY2023, twelve months to 2023-12-31$9.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure0.19Diluted EPS, FY2024, twelve months to 2024-12-31$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure(1.70)Diluted EPS, FY2025, twelve months to 2025-12-31−$1.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure
Free cash flow$m60.3Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $94.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-20, accession 0001628280-24-005620.Capital expenditure: $34.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-20, accession 0001628280-24-005620.Report this figure178Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $194.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-18, accession 0001628280-25-006094.Capital expenditure: $16.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-18, accession 0001628280-25-006094.Report this figure141Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $147.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001628280-26-008656.Capital expenditure: $6.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure17.0Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $24.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001628280-26-008656.Capital expenditure: $7.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure1.2Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $6.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001628280-26-008656.Capital expenditure: $5.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001628280-26-008656.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Medifast Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
RENAISSANCE TECHNOLOGIES LLC2026-06-30$8.3m778,610Added+4,900
Steamboat Capital Partners, LLC2026-06-30$7.5m706,699Reduced−891
SUSQUEHANNA INTERNATIONAL GROUP, LLP2026-06-30$5.8m542,700CallAdded+107,300
TWO SIGMA INVESTMENTS, LP2026-06-30$5.1m481,381Added+143,223
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$4.7m446,614Added+2,147
CHARLES SCHWAB INVESTMENT MANAGEMENT INC2026-06-30$4.2m396,996Reduced−234,543
BlackRock, Inc.2026-06-30$3.9m369,503Reduced−574,950
DIMENSIONAL FUND ADVISORS LP2026-06-30$3.9m363,394Added+1,632
AMERICAN CENTURY COMPANIES INC2026-06-30$3.4m318,911Added+94,631
MORGAN STANLEY2026-06-30$3.1m292,508Reduced−32,804

Recent filings

All 960 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Medifast Inc, recent filings
FiledFormWhat it isAccession number
2026-10-2608:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-067151
2026-08-2116:01 ETSCHEDULE 13D/AOwnership report, active investor, amended0001213900-26-092590
2026-08-0316:50 ET10-QQuarterly reportPeriod 2026-06-300001628280-26-051928
2026-08-0316:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-051845
2026-07-1708:33 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-26-048574
2026-06-0108:59 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001628280-26-039293
2026-05-2616:26 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-26-038109
2026-05-0416:51 ET10-QQuarterly reportPeriod 2026-03-310001628280-26-029898
2026-05-0416:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-029812
2026-04-0616:06 ETDEF 14AProxy statementPeriod 2026-05-190001628280-26-023890

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 17, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested.See the target

About the filer

CIK
910329
Tickers
MED
Exchange
NYSE
SIC code
2090 Miscellaneous Food Preparations & Kindred Products
Sector
Consumer staples
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Accelerated filer<br>Smaller reporting company
Former names
HEALTHRITE INC (to 2001-01-09)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 08:51 ET. Listed shows no prices and gives no investment advice.